[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.173.48.53. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 6, 1909

THE TREATMENT OF ERYSIPELAS BY INOCULATION WITH A SPECIFIC VACCINE

Author Affiliations

TORONTO

From the Department for Therapeutic Inoculation, the Toronto General Hospital: an address given before the Medical Society of the County of New York, Oct. 26, 1908.

JAMA. 1909;LII(10):747-749. doi:10.1001/jama.1909.25420360003002

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

In January of this year we undertook the study of erysipelas with the special consideration of the production of an artificial immunity by inoculation with a vaccine prepared from the Streptococcus erysipelatis of Fehleisen. "True" erysipelas, as you know, is due to an infection of the lymph spaces of the skin by the micro-organism just referred to, with or without involvment of subjacent cellular tissue; and the majority of investigators believe that the streptococcus of erysipelas is the sole or specific cause of the disease. Moreover, many believe that it is identical with the streptococcus causing puerperal septicemia, pyemia, etc. The work of Dean and Petruschky would seem to confirm this view.

From the standpoint of immune therapy it is a matter of some importance to discover whether the disease is one in which the bacteria are localized to the affected part or whether they commonly escape into the blood

First Page Preview View Large
First page PDF preview
First page PDF preview
×